PAR paradigm biopharmaceuticals limited..

LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-13

  1. 2,037 Posts.
    lightbulb Created with Sketch. 365
    True but to be fair I think they were always going to be subject to a favorable response from the FDA which has taken longer than expected
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
36.5¢
Change
-0.020(5.19%)
Mkt cap ! $145.0M
Open High Low Value Volume
39.5¢ 39.5¢ 35.8¢ $295.4K 789.4K

Buyers (Bids)

No. Vol. Price($)
2 1039 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 106563 7
View Market Depth
Last trade - 10.49am 31/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.